A prospective, phase 2, multicentre, open-label, randomized, comparative study to estimate the safety, tolerability, pharmacokinetics, and efficacy of oral SCY-078 vsstandard-of-care following initial intravenous echinocandin therapy in the treatment of..

Talk given at ECCMID 2017 by Peter G. Pappas

Antifungal name: 

Date of article/Start date of trial: 

Thursday, April 27, 2017

Trial phase: 

Phase 2

Computed content type (New antifungal): 

New antifungal drugs